Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis von de Lemos, Mário L, Kang, Isabell, Schaff, Kimberly

Volltext

Defining cytotoxic drugs – you know it when you see it? von de Lemos, Mário L, Badry, Nadine, Conklin, James, Koberinski, Michelle

Volltext

Efficacy of nivolumab four-weekly dosing schedule based on body weight von de Lemos, Mário L, Kung, Carrie, Waignein, Sally

Volltext

Approach to initiating QT-prolonging oncology drugs in the ambulatory setting von de Lemos, Mário L, Kung, Carrie, Kletas, Victoria, Badry, Nadine, Kang, Isabell

Volltext

Clinical considerations of hyaluronidase as an adjunct to subcutaneous rituximab injection von de Lemos, Mário L, Dar Santos, Anne

Volltext

Safe handling of monoclonal antibodies: Too large to be hazardous? von de Lemos, Mário L, Badry, Nadine, Kletas, Victoria, Fabbro, Joan, Tew, Amber

Volltext

Challenges of dispensing costly tablets with short shelf-life von de Lemos, Mário L, Mathers, Brittney, Badry, Nadine, Hamata, Linda, Lo, Kelly

Volltext

Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies von de Lemos, Mário L., Hsieh, Teresa, Hamata, Linda, Levin, Adeera, Swenerton, Ken, Djurdjev, Ognjenka, Vu, Thanh, Hu, Francis, Conklin, James, Malfair Taylor, Suzanne C.

Volltext

Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea? von de Lemos, Mário L, Guenter, Jolene, Kletas, Victoria

Volltext

A deliberative framework to identify the need for real-life evidence building of new cancer drugs after interim funding decision von Leung, Leanne, de Lemos, Mário L, Kovacic, Laurel

Volltext

Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation von de Lemos, Mário L, Markarian, Adeline, Chan, Esther, Schaff, Kimberly, Walisser, Susan

Volltext

Pharmacist prescribing von de Lemos, Mário L

Volltext

Rationalizing the use of auxiliary label for oral oncology drugs von Ng, Tonya, Badry, Nadine, de Lemos, Mário L

Volltext

Evidence-based practice in times of drug shortage von de Lemos, Mário L., Waignein, Sally, de Haan, Marie

Volltext

Adherence with capecitabine: A population-based analysis based on prescription refill data von Kovacic, Laurel, de Haan, Neil, de Lemos, Mário L, Schaff, Kimberly, Walisser, Susan

Volltext

Comment: Evaluation of the Modified Diet in Renal Disease Equation for Calculation of Carboplatin Dose von Lemos, Mário L de, Hamata, Linda, Conklin, James

Volltext

Communicating with patients about chemotherapy costs von de Lemos, Mário L

Volltext

Evaluation of creatinine-based formulas in dosing adjustment of cancer drugs other than carboplatin von Jennings, Sarah, de Lemos, Mário L, Levin, Adeera, Murray, Nevin

Volltext

International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint i... von Walker, Andrew, Chan, Alexandre, Labra, Constanza Cortés, de Lemos, Mario L., Geirnaert, Marc, Albert-Marí, María Asunción, Atik, Elif Aras, Borlagdan, Jared, Crespo, Andrea, Danilak, Melanie, Kandemir, Esin Aysel, Lim, CheaXin, Alabelewe, Ramatu Mas’ud, Mutiara, Rina, Tewthanom, Karunrat, Yim, Barbara, Nakashima, Lynne

Volltext

Potential underdosing of carboplatin in gynecological malignancies von de Lemos, Mário L., Hamata, Linda, Conklin, James, Swenerton, Ken

Volltext